International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Russia · Delayed Price · Currency is RUB

672.00

-1.50 (-0.22%)

At close: Jul 8, 2022

MOEX:GEMA Financials Overview

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	383.73	376.74	348.6	283.51	254.68	265.89
Revenue Growth	7.09%	8.07%	22.96%	11.32%	-4.22%	9.59%
Gross Profit	309.16	304.04	289.89	235.56	203	204.07
Operating Income	182.87	181.8	178.15	149.36	138.6	137.9
Net Income	153.95	158.39	151.22	125.78	98.17	150.74
Earnings Per Share	10.31	10.61	10.13	8.42	6.58	10.10
EPS Growth	-3.04%	4.74%	20.24%	28.13%	-34.88%	22.79%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	335.5	383.58	323.9	196.07	84.87	36.24
Total Debt	229.6	259.78	271.93	259.93	261.34	55.2
Net Cash (Debt)	105.9	123.79	51.96	-63.86	-176.47	-18.96
Net Cash Growth	103.80%	138.23%	-	-	-	-
Net Cash Per Share	7.09	8.29	3.48	-4.28	-11.82	-1.27

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	195.25	209.91	247.6	223.77	241.11	244.51
Capital Expenditures	-7.63	-5.35	-10.59	-14.18	-9.27	-4.68
Free Cash Flow	187.62	204.55	237.02	209.59	231.83	239.82
Free Cash Flow Growth	-	-13.70%	13.08%	-9.59%	-3.33%	81.33%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	80.57%	80.70%	83.16%	83.09%	79.71%	76.75%
Operating Margin	47.66%	48.26%	51.10%	52.68%	54.42%	51.86%
Pretax Margin	40.12%	42.04%	43.38%	44.36%	38.55%	48.58%
Profit Margin	40.12%	42.04%	43.38%	44.37%	38.55%	56.69%
FCF Margin	48.89%	54.30%	67.99%	73.93%	91.03%	90.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	8.650	-	10.100	6.420	8.022	8.650
Dividend Per Share Growth	-	-	57.32%	-19.97%	-7.26%	-
Dividend Yield	1.29%	-	1.50%	0.95%	1.19%	0.91%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	65.18	-	66.35	79.77	102.20	98.94
P/FCF Ratio	54.24	-	42.33	47.87	43.28	62.19
PS Ratio	25.90	-	28.78	35.39	39.40	56.10